The neurocognitive mechanisms of novel treatments in mood disorders (360G-Wellcome-095465_Z_11_Z)
The primary objective for this collaborative doctoral research project between UCL and the NIMH is to investigate the mechanisms underpinning responses to novel treatments in mood disorders (e.g. ketamine, scopolamine, sleep deprivation). Specifically, what are the neurocognitive changes following such treatments, and might we be able to predict who will best respond to treatment and stay well on the basis of neurocognitive markers?
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 70000 |
| Applicant Surname | Lally |
| Approval Committee | WT/NIH Four Year PhD Programme Interview Committee |
| Award Date | 2011-01-27T00:00:00+00:00 |
| Financial Year | 2010/11 |
| Grant Programme: Title | WT/NIH Four Year PhD Studentship |
| Internal ID | 095465/Z/11/Z |
| Lead Applicant | Mr Niall Lally |
| Partnership Name | Wellcome Trust-NIH PhD Studentships |
| Partnership Value | 70000 |
| Planned Dates: End Date | 2015-09-30T00:00:00+00:00 |
| Planned Dates: Start Date | 2011-10-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |
| Sponsor(s) | Dr Carlos Zarate, Prof Geraint Rees |